SCNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Scienture Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$2.92−0.44 (-13.10%)
Close on Oct 19, 2026
- Market cap
- $115.68M
- P/E (TTM)
- –
- Dividend yield
- –
Scienture statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Scienture | Industry median |
|---|---|---|
| Market Cap | $119.91M | $197.05M |
| Enterprise Value | $111.72M | $106.56M |
| PB Ratio | 1.87 | 2.14 |
Income (trailing twelve months)
| Measure | Scienture | Industry median |
|---|---|---|
| Gross Profit | $720.44K | $90.47M |
| Operating Income | -$40.07M | -$21.44M |
| Net Income | -$37.95M | -$22.46M |
| EBITDA | -$40.07M | -$16.91M |
| EPS (Diluted) | -$1.85 | -$0.83 |
Returns
| Measure | Scienture | Industry median |
|---|---|---|
| Return on Equity (ROE) | -53.5% | -53.1% |
| Return on Assets (ROA) | -44.2% | -41.0% |
| Return on Invested Capital (ROIC) | -47.3% | -32.0% |
| Return on Capital Employed (ROCE) | -47.3% | -37.8% |
Growth
| Measure | Scienture | Industry median |
|---|---|---|
| Revenue Growth (3Y CAGR) | -65.2% | 2.25% |
| Revenue Growth (5Y CAGR) | -52.1% | 6.42% |
Balance sheet
| Measure | Scienture | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $8.19M | $62.42M |
| Net Cash (Debt) | $8.19M | $15.68M |
| Net Cash Per Share | $0.20 | $0.65 |
| Equity (Book Value) | $64.10M | $48.79M |
| Book Value Per Share | $1.56 | $1.36 |
| Tangible Book Value | -$5.96M | $23.06M |
| Working Capital | $6.18M | $75.77M |
Financial position
| Measure | Scienture | Industry median |
|---|---|---|
| Current Ratio | 3.04 | 3.30 |
| Quick Ratio | 2.83 | 2.39 |
| Interest Coverage | -13.07 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Scienture | Industry median |
|---|---|---|
| Operating Cash Flow | -$14.44M | -$12.35M |
Efficiency
| Measure | Scienture | Industry median |
|---|---|---|
| Inventory Turnover | 0.50 | 2.67 |
| Profits Per Employee | -$4.74M | -$732.08K |
| Employee Count | 8 | 73 |
Dividends and yields
| Measure | Scienture | Industry median |
|---|---|---|
| Earnings Yield | -31.7% | -21.2% |
Shares
| Measure | Scienture | Industry median |
|---|---|---|
| Shares Outstanding | 41,064,100 | 59,128,900 |
| Shares Change (QoQ) | 1.07% | 0.54% |
| Float | 34,228,200 | 48,744,500 |
| Shares Held by Insiders | 16.6% | 11.8% |
Scores
| Measure | Scienture | Industry median |
|---|---|---|
| Altman Z-Score | 0.24 | 0.10 |
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from Scienture's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.